Modification of experimental Porphyromonas gingivalis murine infection by immunization with a polysaccharide-protein conjugate.
To better understand the role of the capsular polysaccharide in the virulence of Porphyromonas gingivalis, the effect of immunization with a polysaccharide-protein conjugate on experimental murine infection was evaluated. The conjugate was prepared using polysaccharide isolated from P. gingivalis strain ATCC 53977 and bovine serum albumin. One group of 22 mice was immunized by intraperitoneal injection with the conjugate and a control group of 25 mice was similarly immunized with bovine serum albumin. Serum antibody reactive to the polysaccharide, as determined by enzyme-linked immunosorbent assay, was elevated in the group of mice immunized with the polysaccharide-protein conjugate but not in the mice immunized with bovine serum albumin. Both groups of mice were challenged with P. gingivalis strain ATCC 53977 (10(10) cells) administered subcutaneously on the dorsal surface. Following challenge, the mice immunized with the polysaccharide-protein conjugate appeared healthier and demonstrated less weight loss than did the control group of mice. Ulcerative lesions at secondary locations were smaller in mice immunized with the polysaccharide-protein conjugate. Thus, immunization of mice with a conjugate containing P. gingivalis polysaccharide could reduce the severity of but not prevent an invasive infection with P. gingivalis.
Schifferle
R E
RE
Department of Oral Biology, Periodontology and Stomatology, School of Dental Medicine, State University of New York, Buffalo.
Chen
P B
PB
Davern
L B
LB
Aguirre
A
A
Genco
R J
RJ
Levine
M J
MJ
D000818:Animals; D016667:Bacterial Capsules / Q000276:immunology; D016866:Bacteroidaceae Infections / Q000276:immunology* / Q000628:therapy; D004797:Enzyme-Linked Immunosorbent Assay; D007114:Immunization; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D051379:Mice; D008807:Mice, Inbred BALB C; D011135:Polysaccharides, Bacterial / Q000276:immunology*; D016966:Porphyromonas gingivalis / Q000276:immunology* / Q000472:pathogenicity; D018074:Vaccines, Conjugate / Q000276:immunology* / Q000627:therapeutic use; D014774:Virulence
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D011135:Polysaccharides, Bacterial; D018074:Vaccines, Conjugate